MCBR has a provision to facilitate Biopharma companies with GMP lab/infra-structure to start MAHE-Pvt. Partnership research unit at MAHE at a very nominal usage fee or potential option to outsource translational research projects to MCBR.

MCBR is at Advanced stage of collaborative discussions with

??????? Stempeutics 亚洲通_亚洲通官网

?? ? ? ?Esco Aster, Singapore

?? ? ? ?Suma Genomics, 亚洲通_亚洲通官网

?? ? ? ?Kemwell Biopharma Ltd, Bengaluru

?? ? ? ?Novartis, Hyderabad

?? ? ? ?Cytiva, Bengaluru

?? ? ? ?Navitas Life Sciences

?? ? ? ?Aurigene Oncology?

?? ? ? ?Aten Porus Lifesciences Pvt Ltd, Bengaluru

?? ? ? ?Bugworks 亚洲通_亚洲通官网 Pvt Ltd Bengaluru

?? ? ? ?ImmunitasBio Pvt Ltd, Bengaluru

?? ? ? ?NeoDx Biotech Labs Pvt Ltd, Bengaluru??

?? ? ? ?Fibroheal Woundcare Pvt ltd, Bengaluru

We welcome more collaborative initiative to the companies for developing novel Biotherapeutics products.